202 related articles for article (PubMed ID: 27183906)
1. Selection and characterization of DNA aptamer for metastatic prostate cancer recognition and tissue imaging.
Duan M; Long Y; Yang C; Wu X; Sun Y; Li J; Hu X; Lin W; Han D; Zhao Y; Liu J; Ye M; Tan W
Oncotarget; 2016 Jun; 7(24):36436-36446. PubMed ID: 27183906
[TBL] [Abstract][Full Text] [Related]
2. Generating lung-metastatic osteosarcoma targeting aptamers for in vivo and clinical tissue imaging.
Wang L; Li P; Xiao X; Li J; Li J; Yang HH; Tan W
Talanta; 2018 Oct; 188():66-73. PubMed ID: 30029428
[TBL] [Abstract][Full Text] [Related]
3. Metastatic cancer cell and tissue-specific fluorescence imaging using a new DNA aptamer developed by Cell-SELEX.
Yuan B; Jiang X; Chen Y; Guo Q; Wang K; Meng X; Huang Z; Wen X
Talanta; 2017 Aug; 170():56-62. PubMed ID: 28501211
[TBL] [Abstract][Full Text] [Related]
4. A cell-based single-stranded DNA aptamer specifically targets gastric cancer.
Zhang X; Zhang J; Ma Y; Pei X; Liu Q; Lu B; Jin L; Wang J; Liu J
Int J Biochem Cell Biol; 2014 Jan; 46():1-8. PubMed ID: 24501772
[TBL] [Abstract][Full Text] [Related]
5. In vitro selection of DNA aptamers for metastatic breast cancer cell recognition and tissue imaging.
Li X; Zhang W; Liu L; Zhu Z; Ouyang G; An Y; Zhao C; Yang CJ
Anal Chem; 2014 Jul; 86(13):6596-603. PubMed ID: 24892693
[TBL] [Abstract][Full Text] [Related]
6. 3D Cell-SELEX: Development of RNA aptamers as molecular probes for PC-3 tumor cell line.
Souza AG; Marangoni K; Fujimura PT; Alves PT; Silva MJ; Bastos VA; Goulart LR; Goulart VA
Exp Cell Res; 2016 Feb; 341(2):147-56. PubMed ID: 26821206
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Selection of a DNA Aptamer by Cell-SELEX as a Molecular Probe for Cervical Cancer Recognition and Imaging.
Wang J; Gao T; Luo Y; Wang Z; Zhang Y; Zhang Y; Zhang Y; Pei R
J Mol Evol; 2019 Apr; 87(2-3):72-82. PubMed ID: 30659315
[TBL] [Abstract][Full Text] [Related]
8. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
[TBL] [Abstract][Full Text] [Related]
9. DNA aptamer evolved by cell-SELEX for recognition of prostate cancer.
Wang Y; Luo Y; Bing T; Chen Z; Lu M; Zhang N; Shangguan D; Gao X
PLoS One; 2014; 9(6):e100243. PubMed ID: 24956390
[TBL] [Abstract][Full Text] [Related]
10. In vitro selection of DNA aptamers against renal cell carcinoma using living cell-SELEX.
Wang J; Zhang Y; Chen Y; Hong S; Sun Y; Sun N; Pei R
Talanta; 2017 Dec; 175():235-242. PubMed ID: 28841985
[TBL] [Abstract][Full Text] [Related]
11. Selection of DNA aptamers against glioblastoma cells with high affinity and specificity.
Kang D; Wang J; Zhang W; Song Y; Li X; Zou Y; Zhu M; Zhu Z; Chen F; Yang CJ
PLoS One; 2012; 7(10):e42731. PubMed ID: 23056171
[TBL] [Abstract][Full Text] [Related]
12. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
[TBL] [Abstract][Full Text] [Related]
13. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
[TBL] [Abstract][Full Text] [Related]
14. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
[TBL] [Abstract][Full Text] [Related]
15. A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer.
Speransky S; Serafini P; Caroli J; Bicciato S; Lippman ME; Bishopric NH
Breast Cancer Res Treat; 2019 Jul; 176(2):271-289. PubMed ID: 31006104
[TBL] [Abstract][Full Text] [Related]
16. Evolution of DNA aptamers through in vitro metastatic-cell-based systematic evolution of ligands by exponential enrichment for metastatic cancer recognition and imaging.
Li X; An Y; Jin J; Zhu Z; Hao L; Liu L; Shi Y; Fan D; Ji T; Yang CJ
Anal Chem; 2015; 87(9):4941-8. PubMed ID: 25867099
[TBL] [Abstract][Full Text] [Related]
17. Development of a fraction collection approach in capillary electrophoresis SELEX for aptamer selection.
Luo Z; Zhou H; Jiang H; Ou H; Li X; Zhang L
Analyst; 2015 Apr; 140(8):2664-70. PubMed ID: 25728760
[TBL] [Abstract][Full Text] [Related]
18. Evolution of DNA aptamers for malignant brain tumor gliosarcoma cell recognition and clinical tissue imaging.
Wu Q; Wu L; Wang Y; Zhu Z; Song Y; Tan Y; Wang XF; Li J; Kang D; Yang CJ
Biosens Bioelectron; 2016 Jun; 80():1-8. PubMed ID: 26802746
[TBL] [Abstract][Full Text] [Related]
19. Selection and characterization of DNA aptamers specific for Listeria species.
Suh SH; Dwivedi HP; Choi SJ; Jaykus LA
Anal Biochem; 2014 Aug; 459():39-45. PubMed ID: 24857773
[TBL] [Abstract][Full Text] [Related]
20. In vitro selection of DNA aptamers recognizing drug-resistant ovarian cancer by cell-SELEX.
He J; Wang J; Zhang N; Shen L; Wang L; Xiao X; Wang Y; Bing T; Liu X; Li S; Shangguan D
Talanta; 2019 Mar; 194():437-445. PubMed ID: 30609555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
